* Program subject to change
Level: Intermediate
Track: Health Policy & Regulatory
Afschin Gandjour, MD, PhD, MA, MBA
Frankfurt School of Finance & Management, Frankfurt, Germany
Lou Garrison, PhD
University of Washington, Seattle, WA, USA
Marlene Gyldmark, MPhil
Idorsia Pharmaceuticals, Allschwill, Switzerland
Mark Nuijten, MBA, PhD, MD
Ben Gurion University, Be'er Sheva, Israel
Fred W. Sorenson, MSc
Cencora, Basel, Switzerland
Level: Introductory
Track: Methodological & Statistical Research
Sven Klijn, MSc
Bristol Myers Squibb, Utrecht, ZH, Netherlands
William Rawlinson, MPhysPhil
Estima Scientific Ltd, London, United Kingdom
Tim Reason, MSc
Estima Scientific Ltd, South Ruislip, LON, United Kingdom
Track: Health Technology Assessment
William Canestaro, PhD, MSc
Washington Research Foundation, Seattle, WA, USA
Erik Landaas, PhD, MPH
W. L. Gore & Associates, Inc., Flagstaff, AZ, USA
Lotte Steuten, MSc, PhD
Office of Health Economics, London, LON, United Kingdom
Level: Experienced
Track: Real World Data & Information Systems
Felicitas Kuehne, MSc
UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and Health Technology Assessment, Innsbruck, Austria
Nicholas R Latimer, PhD, MSc
University of Sheffield & Delta Hat Limited, Sheffield, United Kingdom
Uwe Siebert, MD, MPH, MSc, ScD
UMIT TIROL - University for Health Sciences and Technology Hall in Tirol, Austria and Harvard Chan School of Public Health Harvard University, Boston, MA, USA
Ulka Campbell, PhD, MPH
Aetion, Inc, New York, NY, USA
Doug Foster, MBA
Advanced Data Sciences, San Francisco, CA, USA
Aaron Kamauu, MPH, MS, MD
Navidence LLC, Bountiful, UT, USA
Leanne Larson, MHA
ZS Associates, Wilmette, IL, USA
Track: Economic Evaluation
Gianluca Baio, PhD
University College London, London, United Kingdom
Rose Hart, PhD
Lumanity Inc., Sheffield, United Kingdom
Felicity Lamrock, PhD
Queens University Belfast, Belfast, ANT, United Kingdom
Howard Thom, MSc, PhD
University of Bristol, Bristol, United Kingdom
Jeremy Rassen, ScD
Aetion, Inc., New York, NY, USA
Sebastian Schneeweiss, MD, ScD
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Shirley Wang, PhD
Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA
Lorne Basskin, PharmD
Strategic Economics Ltd., Cary, NC, USA
Karen L Rascati, PhD, RPh
The University of Texas at Austin, Austin, TX, USA
Mondher Toumi, MD, PhD, MSc
Laboratoire de Santé Publique Aix-Marseille University, Marseille, France
Devin Incerti, PhD
EntityRisk, Inc., San Francisco, CA, USA
Jeroen Jansen, PhD
Department of Clinical Pharmacy, School of Pharmacy, University of California – San Francisco, USA; PrecisionHEOR, Oakland, CA, USA
Track: Study Approaches
Turgay Ayer, PhD
Georgia Institute of Technology, Atlanta, GA, USA
Jagpreet Chhatwal, PhD
Harvard Medical School, Boston, MA, USA
Xiaoyan Wang, PhD
Tulane Univeristy, New Orleans, LA, USA
Hua Xu, PhD
Yale University School of Medicine, New Haven, CT, USA
Josh Byrnes, PhD, MHEcon, BEcon
Griffith University, Brisbane, QLD, Australia
Hwee-Lin Wee, PhD
Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
Track: Patient-Centered Research
Rebecca Crawford, MA
RTI Health Solutions, Manchester, United Kingdom
Lynda Doward, MRes
Arinesalingam Gnanasakthy, MSc, MBA
RTI Health Solutions, Succasunna, NJ, USA
Shanshan Qin, PhD
RTI Health Solutions, Durham, NC, USA
Nicholas J. Rockwood, PhD
RTI Health Solutions, Bend, OR, USA
Wei-Hsuan Jenny Lo-Ciganic, PhD, MSPharm, MS
University of Pittsburgh, Pittsburgh, PA, USA
William Padula, PhD, MSc, MS
University of Southern California, Los Angeles, CA, USA
Elisabeth Fenwick, PhD
OPEN Health Evidence & Access, Oxford, United Kingdom
Bristol-Myers Squibb, Utrecht, ZH, Netherlands
Claire Simons, PhD, MSc, MMATH
OPEN Health - HEOR and Market Access, York, United Kingdom